ROYAL BANK OF CANADA - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 126 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$10,000
-56.5%
3,012
-49.8%
0.00%
Q2 2018$23,000
+53.3%
6,000
+64.2%
0.00%
Q1 2018$15,000
+25.0%
3,654
+39.8%
0.00%
Q4 2017$12,000
-80.6%
2,613
-70.1%
0.00%
Q3 2017$62,000
-81.7%
8,725
-84.1%
0.00%
Q1 2017$338,000
+3.0%
54,822
-2.2%
0.00%
Q4 2016$328,00056,031
+65052.3%
0.00%
Q3 2016$0
-100.0%
86
-17.3%
0.00%
Q2 2016$1,000
-92.3%
104
-96.2%
0.00%
Q1 2016$13,000
-83.3%
2,704
-82.4%
0.00%
Q4 2015$78,000
-79.5%
15,357
-85.8%
0.00%
Q3 2015$381,000
+97.4%
108,180
+459.5%
0.00%
Q2 2015$193,000
+36.9%
19,334
+74.8%
0.00%
Q1 2015$141,000
-68.2%
11,063
-64.8%
0.00%
Q4 2014$444,000
+26.1%
31,415
+22.9%
0.00%
Q3 2014$352,000
+190.9%
25,569
+225.4%
0.00%
Q2 2014$121,000
+8.0%
7,857
+19.6%
0.00%
Q1 2014$112,000
-80.1%
6,572
-84.9%
0.00%
Q4 2013$562,000
+5520.0%
43,422
+4144.6%
0.00%
Q3 2013$10,0001,0230.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Finepoint Capital LP 1,605,800$16,026,0004.65%
Baupost Group 25,791,678$257,401,0004.29%
1492 Capital Management LLC 264,297$2,638,0001.67%
Cormorant Asset Management, LP 826,000$8,243,0001.10%
FALCON POINT CAPITAL, LLC 251,137$2,506,0000.85%
OAK RIDGE INVESTMENTS LLC 3,291,711$32,851,0000.70%
Knoll Capital Management, LLC 200,000$1,996,0000.64%
Rhenman & Partners Asset Management AB 534,000$5,329,0000.64%
Old West Investment Management, LLC 79,667$795,0000.55%
THREE BAYS CAPITAL LP 1,284,000$12,814,0000.53%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders